Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 1
2000 1
2001 1
2002 2
2003 2
2005 2
2006 3
2007 3
2008 6
2009 2
2010 2
2011 5
2012 5
2013 3
2014 7
2015 15
2016 12
2017 17
2018 22
2019 30
2020 35
2021 39
2022 50
2023 54
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

297 results

Results by year

Filters applied: . Clear all
Page 1
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer.
Ivanova M, Porta FM, D'Ercole M, Pescia C, Sajjadi E, Cursano G, De Camilli E, Pala O, Mazzarol G, Venetis K, Guerini-Rocco E, Curigliano G, Viale G, Fusco N. Ivanova M, et al. Among authors: fusco n. Virchows Arch. 2024 Jan;484(1):3-14. doi: 10.1007/s00428-023-03656-w. Epub 2023 Sep 28. Virchows Arch. 2024. PMID: 37770765 Free PMC article. Review.
Metaplastic breast cancer: an all-round multidisciplinary consensus.
Corso G, Criscitiello C, Nicosia L, Pesapane F, Vicini E, Magnoni F, Sibilio A, Zanzottera C, De Scalzi AM, Mannucci S, Marabelli M, Calvello M, Feroce I, Zagami P, Porta FM, Toesca A, Tarantino P, Nicolò E, Mazzarol G, La Vecchia C, Bonanni B, Leonardi MC, Veronesi P, Fusco N. Corso G, et al. Among authors: fusco n. Eur J Cancer Prev. 2023 Jul 1;32(4):348-363. doi: 10.1097/CEJ.0000000000000794. Epub 2023 May 12. Eur J Cancer Prev. 2023. PMID: 37021548
The immunogram of inflammatory breast cancer.
Valenza C, Trapani D, Fusco N, Wang X, Cristofanilli M, Ueno NT, Curigliano G. Valenza C, et al. Among authors: fusco n. Cancer Treat Rev. 2023 Sep;119:102598. doi: 10.1016/j.ctrv.2023.102598. Epub 2023 Jul 8. Cancer Treat Rev. 2023. PMID: 37437342 Review.
ESR1 mutations in HR+/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testing.
Venetis K, Pepe F, Pescia C, Cursano G, Criscitiello C, Frascarelli C, Mane E, Russo G, Taurelli Salimbeni B, Troncone G, Guerini Rocco E, Curigliano G, Fusco N, Malapelle U. Venetis K, et al. Among authors: fusco n. Cancer Treat Rev. 2023 Dec;121:102642. doi: 10.1016/j.ctrv.2023.102642. Epub 2023 Oct 13. Cancer Treat Rev. 2023. PMID: 37864956 Review.
The evolving landscape of anatomic pathology.
Pisapia P, L'Imperio V, Galuppini F, Sajjadi E, Russo A, Cerbelli B, Fraggetta F, d'Amati G, Troncone G, Fassan M, Fusco N, Pagni F, Malapelle U. Pisapia P, et al. Among authors: fusco n. Crit Rev Oncol Hematol. 2022 Oct;178:103776. doi: 10.1016/j.critrevonc.2022.103776. Epub 2022 Aug 5. Crit Rev Oncol Hematol. 2022. PMID: 35934262 Review.
Traumatic Corneal Abrasion.
Fusco N, Stead TG, Lebowitz D, Ganti L. Fusco N, et al. Cureus. 2019 Apr 5;11(4):e4396. doi: 10.7759/cureus.4396. Cureus. 2019. PMID: 31223554 Free PMC article.
297 results